Trevor Grant

Trevor Grant has worked in a variety of roles in the fields of science and medicine since 2008. From 2008 to 2010, they were a Teaching Fellow and B.A./M.A. Candidate in the Department of Biology at Boston University, where they conducted research on the transcription factor LSF and its role in cancer. In 2013, they were an Intern in the Department of Global Biotherapeutics Technologies at Pfizer, where they developed a high throughput screening process to rapidly improve the affinity of antibodies for their targets. From 2012 to 2018, they were a Ph.D. Candidate in the Department of Pharmacology and Experimental Therapeutics at Boston University School of Medicine, where they characterized context-dependent signal transduction networks that selectively promote the survival and proliferation of tumor cells. Since 2018, they have been a Research Scientist at Minerva Biotechnologies.

Trevor Grant obtained their Doctor of Philosophy (Ph.D.) in Biomolecular Pharmacology from Boston University School of Medicine between 2012 and 2017. Trevor also earned a Master of Arts (M.A.) in Biotechnology and a Bachelor of Arts (B.A.) in Biochemistry and Molecular Biology from Boston University between 2005 and 2010.